To further validate the mechanisms of MICU1 induced glycolysis in tumour growth and therapy resistance in patients, we determined expression of pPDH(ser293) and MICU1 in chemoresistant patient TMA using immunohistochemistry. This evidence concerns the gene MICU1 and neoplasm.